Ondine Biomedical Inc. (OBI.L)
GBp 8.13
(4.84%)
GBp 8.13
(4.84%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 703 Thousand CAD | 144.95% |
| 2022 | 287 Thousand CAD | -77.11% |
| 2021 | 1.25 Million CAD | 93.22% |
| 2020 | 649 Thousand CAD | 377.21% |
| 2019 | 136 Thousand CAD | 221.43% |
| 2018 | -112 Thousand CAD | -210.89% |
| 2017 | 101 Thousand CAD | 0.0% |
| 2010 | 1.21 Million CAD | 50.32% |
| 2009 | 811.03 Thousand CAD | 336.43% |
| 2008 | 185.83 Thousand CAD | -77.35% |
| 2007 | 820.64 Thousand CAD | 35.84% |
| 2006 | 604.11 Thousand CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| 2003 | - CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 149.56 Thousand GBP | 0.0% |
| 2023 Q2 | -25.87 Thousand GBP | 0.0% |
| 2023 Q4 | 103.92 Thousand GBP | 0.0% |
| 2023 FY | 703 Thousand CAD | 144.95% |
| 2022 FY | 287 Thousand CAD | -77.11% |
| 2022 Q2 | -47.92 Thousand GBP | 0.0% |
| 2022 Q4 | -60.12 Thousand GBP | 0.0% |
| 2021 FY | 1.25 Million CAD | 93.22% |
| 2020 FY | 649 Thousand CAD | 377.21% |
| 2019 FY | 136 Thousand CAD | 221.43% |
| 2018 FY | -112 Thousand CAD | -210.89% |
| 2017 FY | 101 Thousand CAD | 0.0% |
| 2011 Q1 | 368.19 Thousand CAD | -5.72% |
| 2011 Q2 | 422.96 Thousand CAD | 14.88% |
| 2010 Q2 | 182.78 Thousand CAD | -25.59% |
| 2010 FY | 1.21 Million CAD | 50.32% |
| 2010 Q1 | 245.65 Thousand CAD | -1.29% |
| 2010 Q4 | 390.51 Thousand CAD | 16.23% |
| 2010 Q3 | 335.98 Thousand CAD | 83.81% |
| 2009 Q4 | 248.87 Thousand CAD | 44.09% |
| 2009 FY | 811.03 Thousand CAD | 336.43% |
| 2009 Q1 | 121.85 Thousand CAD | -11.67% |
| 2009 Q2 | 267.59 Thousand CAD | 119.6% |
| 2009 Q3 | 172.72 Thousand CAD | -35.45% |
| 2008 Q1 | 140.3 Thousand CAD | 166.37% |
| 2008 FY | 185.83 Thousand CAD | -77.35% |
| 2008 Q3 | -274.14 Thousand CAD | -250.86% |
| 2008 Q4 | 137.95 Thousand CAD | 150.32% |
| 2008 Q2 | 181.72 Thousand CAD | 29.52% |
| 2007 Q3 | 277.41 Thousand CAD | 19.19% |
| 2007 FY | 820.64 Thousand CAD | 35.84% |
| 2007 Q4 | 52.67 Thousand CAD | -81.01% |
| 2007 Q1 | 257.8 Thousand CAD | 8.25% |
| 2007 Q2 | 232.75 Thousand CAD | -9.72% |
| 2006 Q3 | 188.13 Thousand CAD | 5.8% |
| 2006 FY | 604.11 Thousand CAD | 0.0% |
| 2006 Q4 | 238.15 Thousand CAD | 26.59% |
| 2006 Q2 | 177.82 Thousand CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| 2005 Q1 | - CAD | 0.0% |
| 2005 Q2 | - CAD | 0.0% |
| 2005 Q3 | - CAD | 0.0% |
| 2005 Q4 | - CAD | 0.0% |
| 2004 Q3 | - CAD | 0.0% |
| 2004 Q4 | - CAD | 0.0% |
| 2004 Q2 | - CAD | 0.0% |
| 2004 Q1 | - CAD | 0.0% |
| 2003 FY | - CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2003 Q4 | - CAD | 0.0% |
| 2003 Q3 | - CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2001 Q4 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|